Citation Impact
Citing Papers
Heart Failure Outcomes in Clinical Trials of Glucose-Lowering Agents in Patients with Diabetes
2016
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes
2023 Standout
Sodium–glucose cotransporter 2 inhibitor Dapagliflozin attenuates diabetic cardiomyopathy
2020
The effects of compensated cardiac hypertrophy on dihydropyridine and ryanodine receptors in rat, ferret and guinea-pig hearts
1995
Targeting autophagy in obesity: from pathophysiology to management
2018
Effects of empagliflozin on the urinary albumin-to-creatinine ratio in patients with type 2 diabetes and established cardiovascular disease: an exploratory analysis from the EMPA-REG OUTCOME randomised, placebo-controlled trial
2017
Reduction of calcium-independent transient outward potassium current density in DOCA salt hypertrophied rat ventricular myocytes
1994
Molecular Genetics of Na,K-ATPase
1990
Cyclic GMP signaling and regulation of SERCA activity during cardiac myocyte contraction
2005
Renoprotective effects of sodium-glucose cotransporter-2 inhibitors
2018
Depressed mitochondrial transcription factors and oxidative capacity in rat failing cardiac and skeletal muscles
2003
SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
2018 Standout
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
2016 Standout
Exercise-Induced Oxidative Stress: Cellular Mechanisms and Impact on Muscle Force Production
2008 Standout
Mechanisms of Cardiorenal Effects of Sodium-Glucose Cotransporter 2 Inhibitors
2020
The Failing Heart — An Engine Out of Fuel
2007 Standout
Cardiac and Renal Effects of Sodium-Glucose Co-Transporter 2 Inhibitors in Diabetes
2018
Expression of dihydropyridine receptor (Ca2+ channel) and calsequestrin genes in the myocardium of patients with end-stage heart failure.
1992
Recommendations for Chamber Quantification: A Report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, Developed in Conjunction with the European Association of Echocardiography, a Branch of the European Society of Cardiology
2005 Standout
Isozymes of the Na+/K+-ATPase
1989
Mitochondrial creatine kinase in human health and disease
2005
Energy metabolism in heart failure
2003
β2‐Adrenergic receptor overexpression in the developing mouse heart: evidence for targeted modulation of ion channels
1999 StandoutNobel
The changing landscape of atherosclerosis
2021 StandoutNature
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Characterisation of subtypes of the P2X and P2Y families of ATP receptors in the foetal human heart
1998
Thyroid Hormone and the Cardiovascular System
2001 Standout
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
Biological Functions of Autophagy Genes: A Disease Perspective
2019 Standout
Altered inotropic response of endothelin-1 in cardiomyocytes from rats with isoproterenol-induced cardiomyopathy
1998
Sodium–glucose cotransporter-2 inhibition and the potential for renal protection in diabetic nephropathy
2014
Heme Oxygenase-1/Carbon Monoxide: From Basic Science to Therapeutic Applications
2006 Standout
Overexpression of nerve growth factor in the heart alters ion channel activity and β‐adrenergic signalling in an adult transgenic mouse
1998
Reactive oxygen species (ROS) as pleiotropic physiological signalling agents
2020 Standout
Rationale, design, and baseline characteristics of a randomized, placebo-controlled cardiovascular outcome trial of empagliflozin (EMPA-REG OUTCOME™)
2014
Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association
2021 Standout
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
2017 Standout
Heterogeneity of the early outward current in ventricular cells isolated from normal and hypertrophied rat hearts.
1993
Pharmacodynamics, Efficacy and Safety of Sodium–Glucose Co-Transporter Type 2 (SGLT2) Inhibitors for the Treatment of Type 2 Diabetes Mellitus
2014
Effect of Carvedilol on Survival in Severe Chronic Heart Failure
2001 Standout
Role of mechanical and hormonal factors in cardiac remodeling and the biologic limits of myocardial adaptation
1993
Myocardial Substrate Metabolism in the Normal and Failing Heart
2005 Standout
Epicardial adipose tissue in contemporary cardiology
2022
Cardiac-Resynchronization Therapy with or without an Implantable Defibrillator in Advanced Chronic Heart Failure
2004 Standout
Thyroidal enhancement of rat myocardial Na,K-ATPase: Preferential expression of α2 activity and mRNA abundance
1990
Peroxynitrite induced nitration and inactivation of myofibrillar creatine kinase in experimental heart failure
2001
Physiology and Pathophysiology of Purinergic Neurotransmission
2007 Standout
Clinician’s Guide to Cardiopulmonary Exercise Testing in Adults
2010 Standout
Mitochondrial Membrane Permeabilization in Cell Death
2007 Standout
Changes in Gene Expression during Cardiac Growth
1991
Effects of peroxynitrite on isolated cardiac trabeculae: selective impact on myofibrillar energetic controllers
2003
Oxidative stress of myosin contributes to skeletal muscle dysfunction in rats with chronic heart failure
2006
Cardio-renal protection with empagliflozin
2016
Diminished toxicity of ouabain in the hypertrophied rat heart
1989
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
1999 Standout
Heart failure: a model of cardiac and skeletal muscle energetic failure
2006
Regulation of cardiac hypertrophy by intracellular signalling pathways
2006 Standout
Sodium Glucose Co-transporter 2 Inhibitors and Heart Failure
2019
The density of ryanodine receptors decreases with pressure overload‐induced rat cardiac hypertrophy
1991
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
2015 Standout
Cardiomyopathy of Overload
1990
Beta adrenergic and muscarinic receptors in compensatory cardiac hypertrophy of the adult rat
1993
Cardiac hypertrophy, arrhythmogenicity and the new myocardial phenotype. II. The cellular adaptational process
1997
Phospholipase C and cAMP-dependent positive inotropic effects of ATP in mouse cardiomyocytes via P2Y-like receptors
2005
Reactive Oxygen Comes of Age: Mechanism-Based Therapy of Diabetic End-Organ Damage
2019
PKA Phosphorylation Dissociates FKBP12.6 from the Calcium Release Channel (Ryanodine Receptor)
2000 Standout
SGLT-2 inhibitors: Their pleiotropic properties
2016
Effects of supplemental oxygen administration on coronary blood flow in patients undergoing cardiac catheterization
2005
Effects of empagliflozin on blood pressure and markers of arterial stiffness and vascular resistance in patients with type 2 diabetes
2015
Expression of a β-adrenergic receptor kinase 1 inhibitor prevents the development of myocardial failure in gene-targeted mice
1998 StandoutNobel
Fibrosis, not cell size, delineates β-myosin heavy chain reexpression during cardiac hypertrophy and normal aging in vivo
2006 StandoutNobel
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
2005 Standout
2018
Energetic Crosstalk Between Organelles
2001
Inflammation as a Risk Factor for Atrial Fibrillation
2003 Standout
Endothelial Nitric Oxide Synthase in Vascular Disease
2006 Standout
Trophic Effect of Human Pericardial Fluid on Adult Cardiac Myocytes
1997
Molecular Physiology of P2X Receptors
2002 Standout
Myocardial Fatty Acid Metabolism in Health and Disease
2010 Standout
Adenosine 5′-Triphosphate: a P2-Purinergic Agonist in the Myocardium
2001
Distribution of purinergic P2X receptors in the rat heart
1999
Regression of Left Ventricular Hypertrophy Prevents Ischemia-Induced Lethal Arrhythmias
1995
A novel phospholipase C- and cAMP-independent positive inotropic mechanism via a P2 purinoceptor
1997
Fiber Types in Mammalian Skeletal Muscles
2011 Standout
Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes
2020 Standout
Alteration of Na,K-ATPase subunit mRNA and protein levels in hypertrophied rat heart.
1994
Sudden Cardiac Death
1998 Standout
Endurance training induces muscle-specific changes in mitochondrial function in skinned muscle fibers
2002
Probing SGLT2 as a therapeutic target for diabetes: Basic physiology and consequences
2015
Left Ventricular or Biventricular Pacing Improves Cardiac Function at Diminished Energy Cost in Patients With Dilated Cardiomyopathy and Left Bundle-Branch Block
2000
Ionic Remodeling Underlying Action Potential Changes in a Canine Model of Atrial Fibrillation
1997
Sodium Glucose Cotransporter 2 Inhibitors in the Treatment of Diabetes Mellitus
2016
Cardiovascular and Renal Outcomes With Canagliflozin According to Baseline Kidney Function
2018
Aquaporin-1 water channel protein in lung: ontogeny, steroid-induced expression, and distribution in rat.
1996 StandoutNobel
Oxidative capacity in failing hearts
2003
Increased Cardiac Sympathetic Activity and Insulin-Like Growth Factor-I Formation Are Associated With Physiological Hypertrophy in Athletes
2001
Temporally Controlled Onset of Dilated Cardiomyopathy Through Disruption of the SRF Gene in Adult Heart
2005
Voluntary physical activity alterations in endothelial nitric oxide synthase knockout mice
2004
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Ionic Mechanism of Action Potential Prolongation in Ventricular Myocytes From Dogs With Pacing-Induced Heart Failure
1996
Enhanced Na + -Ca 2+ Exchange in the Infarcted Heart
1997
Overexpression of the Cardiac β2-Adrenergic Receptor and Expression of a β-Adrenergic Receptor Kinase-1 (βARK1) Inhibitor Both Increase Myocardial Contractility but Have Differential Effects on Susceptibility to Ischemic Injury
1999 StandoutNobel
A Preliminary Study of Growth Hormone in the Treatment of Dilated Cardiomyopathy
1996
Tissue-specific and developmental regulation of rat Na,K-ATPase catalytic alpha isoform and beta subunit mRNAs.
1988
P2 purinergic receptor activation enhances cardiac contractility in isolated rat and mouse hearts
2001
Defective Excitation-Contraction Coupling in Experimental Cardiac Hypertrophy and Heart Failure
1997 Science
Impaired Myofibrillar Energetics and Oxidative Injury During Human Atrial Fibrillation
2001
Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis
2008 Standout
Effects of Hypertrophy on Regional Action Potential Characteristics in the Rat Left Ventricle
1997
On the pivotal role of PPARa in adaptation of the heart to hypoxia and why fat in the diet increases hypoxic injury
2016 StandoutNobel
Mitochondrial pathology in cardiac failure
2001
Molecular Mechanisms of Myocardial Remodeling
1999 Standout
Mitochondrial ATPase and high-energy phosphates in failing hearts
2001
Dapagliflozin in Patients with Chronic Kidney Disease
2020 Standout
Effect of Endothelin-1 on Actomyosin ATPase Activity
1996
Sodium/Calcium Exchange: Its Physiological Implications
1999 Standout
Limitation of Excessive Extracellular Matrix Turnover May Contribute to Survival Benefit of Spironolactone Therapy in Patients With Congestive Heart Failure
2000 Standout
Enhanced Na(+)-Ca2+ exchange activity in cardiomyopathic Syrian hamster.
1994
Is the Failing Heart Energy Starved?
2004
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
2018 Standout
Functional coupling of creatine kin a ses in muscles: Species and tissue specificity
1998
Works of Eric Mayoux being referenced
SGLT2 Inhibition by Empagliflozin Promotes Fat Utilization and Browning and Attenuates Inflammation and Insulin Resistance by Polarizing M2 Macrophages in Diet-induced Obese Mice
2017
Effect of pressure overload on cardiac Ca2+ antagonist binding sites of guinea pig. Comparison with the adaptational response of the hypertrophied rat heart
1991
Sodium glucose transporter 2 (SGLT2) inhibition with empagliflozin improves cardiac diastolic function in a female rodent model of diabetes
2017
Empagliflozin Improves Left Ventricular Diastolic Dysfunction in a Genetic Model of Type 2 Diabetes
2017
Effects of C‐type natriuretic peptide on rat cardiac contractility
1999
The Sodium-Glucose Co-Transporter 2 Inhibitor Empagliflozin Improves Diabetes-Induced Vascular Dysfunction in the Streptozotocin Diabetes Rat Model by Interfering with Oxidative Stress and Glucotoxicity
2014
Empagliflozin Increases Cardiac Energy Production in Diabetes
2018
Adaptational Process of the Cardiac Ca2+ Channels to Pressure Overload
1988
The SGLT2 inhibitor empagliflozin improves the primary diabetic complications in ZDF rats
2017
Normal responsiveness to external Ca and to Ca-channel modifying agents in hypertrophied rat heart
1990
Mechanical properties of rat cardiac skinned fibers are altered by chronic growth hormone hypersecretion.
1993
SGLT2 inhibitor empagliflozin reduces renal growth and albuminuria in proportion to hyperglycemia and prevents glomerular hyperfiltration in diabetic Akita mice
2013
The SGLT2 inhibitor empagliflozin ameliorates early features of diabetic nephropathy in BTBR ob/ob type 2 diabetic mice with and without hypertension
2014
Identification of two isoforms of the catalytic subunit of Na,K-ATPase in myocytes from adult rat heart.
1987
CV Protection in the EMPA-REG OUTCOME Trial: A “Thrifty Substrate” Hypothesis
2016
Effects of acidosis and alkalosis on mechanical properties of hypertrophied rat heart fiber bundles
1994
Paracrine effects of endocardial endothelial cells on myocyte contraction mediated via endothelin
1993
The mechanism of positive inotropy induced by adenosine triphosphate in rat heart.
1990
Empagliflozin, via Switching Metabolism Toward Lipid Utilization, Moderately Increases LDL Cholesterol Levels Through Reduced LDL Catabolism
2016
Increase in SGLT1-mediated transport explains renal glucose reabsorption during genetic and pharmacological SGLT2 inhibition in euglycemia
2013
Subcellular Creatine Kinase Alterations
1999
Calcium current in single cells isolated from normal and hypertrophied rat heart. Effects of beta-adrenergic stimulation.
1990